Realta Investment Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-123
| Closed | -$5.31K | – | 831 |
|
|
2024
Q1 | $5.31K | Buy |
+123
| New | +$5.31K | ﹤0.01% | 739 |
|
|
2023
Q4 | – | Sell |
-123
| Closed | -$5.04K | – | 813 |
|
|
2023
Q3 | $5.04K | Sell |
123
-100
| -45% | -$4.1K | ﹤0.01% | 718 |
|
|
2023
Q2 | $9.14K | Buy |
+223
| New | +$9.14K | ﹤0.01% | 724 |
|
|
2023
Q1 | – | Sell |
-223
| Closed | -$9.13K | – | 838 |
|
|
2022
Q4 | $9.13K | Hold |
223
| – | – | ﹤0.01% | 719 |
|
|
2022
Q3 | $9K | Buy |
+223
| New | +$9K | ﹤0.01% | 711 |
|
|
2020
Q1 | – | Sell |
-608
| Closed | -$25K | – | 1435 |
|
|
2019
Q4 | $25K | Sell |
608
-100
| -14% | -$4.11K | 0.01% | 856 |
|
|
2019
Q3 | $26K | Hold |
708
| – | – | 0.01% | 847 |
|
|
2019
Q2 | $28K | Hold |
708
| – | – | 0.01% | 827 |
|
|
2019
Q1 | $29K | Buy |
+708
| New | +$29K | 0.01% | 678 |
|